Immunotherapy Drugs Market Size Projected to Reach $740 billion by 2034 | 11.4%

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Immunotherapy Drugs Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to Straits Research, the global immunotherapy drugs market size was valued at $290 billion in 2025 and is projected to grow from $320 billion in 2026 to $740 billion by 2034, registering a CAGR of 11.4% during the forecast period 2026–2034.

• The vaccines segment is expected to have a CAGR of 14% during the forecast period.
• North America is expected to lead the market during the forecast period, owing to rising incidence of cancer and well-established hospitals and cancer centers.
• Research related to biology and immune sciences enables more understanding of immune checkpoints, such as PD-1, PD-L1, CTLA-4, and LAG-3, which leads to higher use of first-in-class therapies.
• Saudi Arabia is expected to lead the Middle East & Africa market with significantly higher per-capita healthcare expenditure under the Saudi Vision 2030.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

1. By Type
   1. Monoclonal Antibodies
   2. Vaccines
   3. Immunomodulators
2. By Indication
   1. Cancer
   2. Autoimmune and Inflammatory Diseases
   3. Infectious Diseases
3. By Region
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East and Africa
   5. Latin America